Det primære mål for virkningen var antallet af patienter uden blødninger (hæmostase) på applikationsstedet fire minutter efter, at der var blevet anvendt Evicel eller manuel kompression.
The main measure of effectiveness was the number of patients with no bleeding (haemostasis) at the site of application, four minutes after having received Evicel or manual compression.